Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inosine regrows nerves in spinal cord injuries:

This article was originally published in Clinica

Executive Summary

Administration of the nerve growth factor, inosine, to the motor cortex of rats with severed spinal cord motor nerve fibres led to nerve regrowth through the injury, researchers at Boston Life Sciences have reported. The Massachusetts-based company is developing growth factors for the treatment of spinal cord injuries and stroke, and now hopes to repeat the studies in nonhuman primates as a prelude to clinical trials.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT076095

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel